LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative Radiopharmaceuticals Oncoinvent is actively developing cutting-edge alpha-emitting radiopharmaceutical products aimed at treating metastatic cancers, representing a growing demand for specialized medical radioisotopes and precision cancer therapies.

Strategic Mergers The recent merger with BerGenBio after its lead drug failure suggests a strategic shift towards radiopharma, opening opportunities for collaborations, licensing, and joint ventures within the radiopharmaceutical space.

Research Facility Expansion Partnerships like the one with ARTBIO highlight Oncoinvent's focus on enhancing laboratory capabilities, creating opportunities for vendors supplying GMP-compliant lab equipment, radiochemistry supplies, and manufacturing technology.

Leadership & Growth With recent appointments of a new CEO and CFO, Oncoinvent is positioning itself for growth and increased investor confidence, making it an ideal target for services and solutions that support clinical development and financial management.

Niche Market Focus Operating within a specialized sector with relatively small revenue and funding levels, Oncoinvent presents opportunities for targeted sales of niche biotech tools, regulatory consulting, and clinical trial support tailored for early-stage radiopharma companies.

Similar companies to Oncoinvent ASA

Oncoinvent ASA Tech Stack

Oncoinvent ASA uses 8 technology products and services including MySQL, oEmbed, Shopify, and more. Explore Oncoinvent ASA's tech stack below.

  • MySQL
    Database
  • oEmbed
    Dev Tools
  • Shopify
    E-commerce
  • jQuery
    Javascript Libraries
  • Elementor
    Page Builders
  • Priority Hints
    Performance
  • reCAPTCHA
    Security
  • Bootstrap
    UI Frameworks

Media & News

Oncoinvent ASA's Email Address Formats

Oncoinvent ASA uses at least 1 format(s):
Oncoinvent ASA Email FormatsExamplePercentage
Last@oncoinvent.comDoe@oncoinvent.com
46%
First.Last@oncoinvent.comJohn.Doe@oncoinvent.com
37%
First.Middle.Last@oncoinvent.comJohn.Michael.Doe@oncoinvent.com
16%
FirstL@oncoinvent.comJohnD@oncoinvent.com
1%

Frequently Asked Questions

What is Oncoinvent ASA's phone number?

Minus sign iconPlus sign icon You can contact Oncoinvent ASA's main corporate office by phone at
+47-22-18-3****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Oncoinvent ASA's official website and social media links?

Minus sign iconPlus sign iconOncoinvent ASA's official website is oncoinvent.com and has social profiles on LinkedInCrunchbase.

What is Oncoinvent ASA's SIC code NAICS code?

Minus sign iconPlus sign iconOncoinvent ASA's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Oncoinvent ASA have currently?

Minus sign iconPlus sign iconAs of December 2025, Oncoinvent ASA has approximately 46 employees across 1 continents, including Europe. Key team members include Chief Executive Officer: O. S.Chief Operating Officer: G. E. H.Chief Production Officer: K. L.. Explore Oncoinvent ASA's employee directory with LeadIQ.

What industry does Oncoinvent ASA belong to?

Minus sign iconPlus sign iconOncoinvent ASA operates in the Biotechnology Research industry.

What technology does Oncoinvent ASA use?

Minus sign iconPlus sign iconOncoinvent ASA's tech stack includes MySQLoEmbedShopifyjQueryElementorPriority HintsreCAPTCHABootstrap.

What is Oncoinvent ASA's email format?

Minus sign iconPlus sign iconOncoinvent ASA's email format typically follows the pattern of Last@oncoinvent.com. Find more Oncoinvent ASA email formats with LeadIQ.

How much funding has Oncoinvent ASA raised to date?

Minus sign iconPlus sign icon As of December 2025, Oncoinvent ASA has raised $12M in funding. The last funding round occurred on Dec 04, 2024 for $12M.

When was Oncoinvent ASA founded?

Minus sign iconPlus sign iconOncoinvent ASA was founded in 2010.

Oncoinvent ASA

Biotechnology ResearchOslo, Norway11-50 Employees

Oncoinvent is a clinical stage company committed to developing new innovative radiopharmaceutical products for better treatment options for cancer patients.

Radspherin®, the company’s lead product candidate is a novel alpha-emitting radioactive microsphere suspension designed for treatment of metastatic cancers in body cavities. Radspherin® has shown strong and consistent anticancer activity at essentially non-toxic doses in preclinical studies and is anticipated to potentially treat several forms of metastatic cancer.

Situated in Oslo, Oncoinvent’s main offices include modern laboratory facilities suitable for cGMP and radiopharmaceutical manufacture for clinical trials and research. The development programs of the company include radiotherapeutic and radioimmunotherapeutic products with focus on alpha-emitting radionuclides for treatment of various solid cancers.

Section iconCompany Overview

Phone number
+47-22-18-3****
Website
oncoinvent.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2010
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $12M

    Oncoinvent ASA has raised a total of $12M of funding over 4 rounds. Their latest funding round was raised on Dec 04, 2024 in the amount of $12M.

  • $1M$10M

    Oncoinvent ASA's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $12M

    Oncoinvent ASA has raised a total of $12M of funding over 4 rounds. Their latest funding round was raised on Dec 04, 2024 in the amount of $12M.

  • $1M$10M

    Oncoinvent ASA's revenue is estimated to be in the range of $1M$10M

Company Leadership

  • Stylized image of a person
    O. S.
    Chief Executive Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    G. E. H.
    Chief Operating Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    K. L.
    Chief Production Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    I. E.
    Head Of Quality Control
    Phone icon
    Mobile Phone
  • Stylized image of a person
    K. T. J.
    Head Of Quality Control
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    K. T. J.
    Head Of Quality Control
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. B.
    Head Of Regulatory Affairs
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. C. A.
    Head Of Qa/Qp
    Phone icon
    Mobile Phone
  • Stylized image of a person
    R. T.
    Senior Financial Controller
    Phone icon
    Mobile Phone
  • Stylized image of a person
    H. M. H.
    Pharmaceutical Manufacturing Director
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.